U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 207

1.
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2024 Mar; 45(2): 81–83. doi: 10.2500/aap.2024.45.240003
PMCID:
PMC10926181
ArticlePDF–33K
2.
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2024 Jan; 45(1): 1–4. doi: 10.2500/aap.2024.45.230086
PMCID:
PMC10762648
ArticlePDF–68K
3.
Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients
Helene Karcher, Matthias Schoenberger, Tejaswini Rayban, Caoimhe Kelly, Andrew Heaney, Alexander Mackay
Allergy Asthma Proc. 2023 Nov; 44(6): 422–428. doi: 10.2500/aap.2023.44.230061
PMCID:
PMC10629374
ArticlePDF–1.0M
4.
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS
Maria D. LaRusso, Cesar E. Abadia
Allergy Asthma Proc. 2023 Sep; 44(5): 361–367. doi: 10.2500/aap.2023.44.230049
PMCID:
PMC10476495
ArticlePDF–101K
5.
A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2023 Jul; 44(4): 217–219. doi: 10.2500/aap.2023.44.230037
PMCID:
PMC10362968
ArticlePDF–57K
6.
A tribute to allergy and immunology fellowship training program directors and to the fellows they train
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2023 May; 44(3): 155–157. doi: 10.2500/aap.2023.44.230017
PMCID:
PMC10165681
ArticlePDF–54K
7.
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being
Sandra C. Christiansen, Camila Lopes Veronez, Tukisa D. Smith, Marc A. Riedl, Bruce L. Zuraw
Allergy Asthma Proc. 2023 Mar; 44(2): 115–121. doi: 10.2500/aap.2023.44.220096
PMCID:
PMC9999437
ArticlePDF–89K
8.
Asthma in pregnancy
Daniela C. Bravo-Solarte, Danna P. Garcia-Guaqueta, Sergio E. Chiarella
Allergy Asthma Proc. 2023 Jan; 44(1): 24–34. doi: 10.2500/aap.2023.44.220077
PMCID:
PMC9809179
ArticlePDF–457K
9.
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course
Nida Oztop, Semra Demir, Ilkim Deniz Toprak, Derya Unal, Aslı Gelincik
Allergy Asthma Proc. 2022 Nov; 43(6): 546–554. doi: 10.2500/aap.2022.43.220069
PMCID:
PMC9645734
ArticlePDF–631K
10.
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2022 Nov; 43(6): 471–473. doi: 10.2500/aap.2022.43.220081
PMCID:
PMC9645732
ArticlePDF–61K
11.
Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns
Timothy Kaddis, Shyam Joshi, Karen M. Anstey
Allergy Asthma Proc. 2022 Sep; 43(5): 431–434. doi: 10.2500/aap.2022.43.220051
PMCID:
PMC9465645
ArticlePDF–64K
12.
The long COVID syndrome: A conundrum for the allergist/immunologist
Joseph A. Bellanti
Allergy Asthma Proc. 2022 Sep; 43(5): 368–374. doi: 10.2500/aap.2022.43.220059
PMCID:
PMC9465643
ArticlePDF–728K
13.
Eosinophilic esophagitis: from discovery to effective treatment
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2022 May; 43(3): 175–177. doi: 10.2500/aap.2022.43.220025
PMCID:
PMC9106097
ArticlePDF–56K
14.
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome
Danilo Buonsenso, Michele Piazza, Attilio L. Boner, Joseph A. Bellanti
Allergy Asthma Proc. 2022 May; 43(3): 187–193. doi: 10.2500/aap.2022.43.220018
PMCID:
PMC9106095
ArticlePDF–790K
15.
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2022 Mar; 43(2): 93–95. doi: 10.2500/aap.2022.43.220008
PMCID:
PMC8984762
ArticlePDF–56K
16.
Population-based incidence of food allergies in Olmsted County over 17 years
Yahya Almodallal, Amy L. Weaver, Avni Y. Joshi
Allergy Asthma Proc. 2022 Jan; 43(1): 44–49. doi: 10.2500/aap.2022.43.210088
PMCID:
PMC9274936
ArticlePDF–820K
17.
Evaluation and management of adverse reactions to the COVID-2019 vaccines
Joseph A. Bellanti, Russell A. Settipane
Allergy Asthma Proc. 2022 Jan; 43(1): 1–4. doi: 10.2500/aap.2022.43.210118
PMCID:
PMC8749252
ArticlePDF–64K
18.
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2
Eli Magen, Avi Yakov, Ilan Green, Ariel Israel, Shlomo Vinker, Eugene Merzon
Allergy Asthma Proc. 2022 Jan; 43(1): 30–36. doi: 10.2500/aap.2022.43.210111
PMCID:
PMC8749250
ArticlePDF–91K
19.
Diverging trends of respiratory allergies and eczema in Greek schoolchildren: Six surveys during 1991–2018
Styliani Malliori, Alexandros Ntzounas, Panagiotis Lampropoulos, Eleana Koliofoti, Kostas N. Priftis, Sotirios Fouzas, Michael B. Anthracopoulos
Allergy Asthma Proc. 2022 Jan; 43(1): e17–e24. doi: 10.2500/aap.2022.43.210110
PMCID:
PMC8749244
ArticlePDF–1.3M
20.
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose
Megan C. Gallagher, Sarah Haessler, Elizabeth Pecoy-Whitcomb, Jonathan Bayuk
Allergy Asthma Proc. 2022 Jan; 43(1): 37–39. doi: 10.2500/aap.2022.43.210100
PMCID:
PMC8749240
ArticlePDF–310K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center